Company profilePharmaceutical#932 of 1,318 in Pakistan✓ No DRAP alerts

Stiefel Laboratories Pak ( Pvt) Ltd.

Pharmaceutical company · 5 brands · 1 molecules

Ranked #18 of 58 companies in Skin Conditions

5 registered products 2 pharmaceutical brands 1 distinct molecules 0 DRAP alerts

Company overview

5
registered products
2
pharmaceutical brands
1
distinct molecules
3
therapeutic classes
0
DRAP alerts

Stiefel Laboratories Pak ( Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 5 product registrations across 1 distinct molecules. Its portfolio is concentrated in Skin Conditions and Unmapped-Medicine. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Stiefel

4 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Unmapped-Medicine 1

Top molecules by brand count

Clobetasol2 brands

Therapeutic classes

Skin Conditions · 4Unmapped-Medicine · 1Corticosteroid, Plain · 1

Conditions treated

Eczema/Psoriasis/Dermatitis · 3Acne/Topical · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO2 products · Rs 211.44 – Rs 218
Servaid5 products · Rs 80.85 – Rs 990
Median across source: Rs 214.72

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

P.D.H. PHARMACEUTICALS (PVT) LTD. holds 77 molecules not in this portfolio
AmikacinAmoxicillinAmoxicillin BaseAmoxycillinAmoxycillin BaseAmoxycillin Sodium Amoxycillin Base
BIO LABS (PVT) LTD. holds 139 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
PLATINUM PHARMACEUTICALS (PVT.) LTD. holds 124 molecules not in this portfolio
AlfacalcidolAmlodipineAmlodipine Base 10MgAmlodipine Base………….5MgAripiprazoleArtemether

Get the full profile for Stiefel

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.